Markers of endothelial dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, including in Combination with Type 2 Diabetes Mellitus

7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

The prevalence of coronary heart disease (CHD) and type 2 diabetes mellitus (type 2 diabetes) in Russia and in the world continues to increase. Despite the prevention and optimization of therapy, CHD retains its leadership among all causes of death, and the mortality rate from type 2 diabetes and its complications gradually increases too. To improve the treatment of the above mentioned diseases, it is necessary to clarify the pathogenetic mechanisms of their development. The formation of endothelial dysfunction, characterized by an increase in the level of cell adhesion molecules and vasoconstriction, is a common link characteristic for the course and progression of CHD and type 2 diabetes. This article presents an analysis of pre- and clinical studies on the role of endothelial dysfunction markers: cell adhesion molecules (E-selectin), vasoconstriction (endothelin-1) and von Willebrand factor in patients with CHD, including those with type 2 diabetes mellitus.

Cite

CITATION STYLE

APA

Zhito, A. V., Iusupova, A. O., Privalova, E. V., Khabarova, N. V., & Belenkov, Y. N. (2019). Markers of endothelial dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, including in Combination with Type 2 Diabetes Mellitus. Rational Pharmacotherapy in Cardiology, 15(6), 892–899. https://doi.org/10.20996/1819-6446-2019-15-6-892-899

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free